The source details the construction of what is described as the world’s largest 3D printed drug factory in Nanjing, China, by the company Triastek. This groundbreaking facility is designed to produce up to 300 million tablets annually using fully digital, autonomous 3D printing systems, bypassing traditional pharmaceutical manufacturing steps. The article discusses how this additive manufacturing method allows for complex drug designs, such as time-release tablets, and notes that Triastek is only the second company globally to commercialize 3D printed drugs, following Aprecia’s FDA approval in 2015. While the technology faces hurdles like regulatory approval and ensuring consistency at scale, the factory represents a significant step toward personalized medicine and positions China as a potential leader in digital pharma.